翰宇药业：关于向深圳市高新投集团有限公司及其下属子公司融资的公告

Core Points - Han Yu Pharmaceutical announced a financing plan to raise up to 700 million RMB from Shenzhen High-tech Investment Group and its subsidiaries [2] - The financing will cover multiple products and has a term of no more than 12 months [2] - The financing will be secured by assets from the company's Pingshan branch and Dali subsidiary [2]